Clinical TrialsSearch results
Number of results: 61097
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase III study of LDK378 versus standard chemotherapy in ALK+ advanced NSCLC patients who have been previously treated with chemotherapy and crizotinib
- Novartis Pharma
- 2013-09-11
Other
- A phase I study of oral BGJ398 in Asian patients
- 2013-09-24
Other
- A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
- 2015-06-11
Other
- -
- 2017-10-25
Other
- -
- 2015-10-23
Other
- -
- 2015-07-09